Your browser doesn't support javascript.
loading
PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.
Chen, Zhiyuan; Zhong, Shanliang; Zhang, Zhengdong; Tang, Jinhai.
  • Chen Z; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Zhong S; Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhang Z; Center of Clinical Laboratory Science, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Tang J; Department of Environmental Genomics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangning District, China. drzdzhang@njmu.edu.cn.
Biochem Genet ; 61(4): 1369-1386, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36598702
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article